Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunoprecipitation [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-567 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-567, RRID:AB_10001551
- Product name
- Rabbit Polyclonal TAF15 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 ul
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C. Do not freeze.
Submitted references Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.
The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex.
Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Chi B, O'Connell JD, Yamazaki T, Gangopadhyay J, Gygi SP, Reed R
Scientific reports 2018 Jun 8;8(1):8755
Scientific reports 2018 Jun 8;8(1):8755
The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex.
Chi B, O'Connell JD, Iocolano AD, Coady JA, Yu Y, Gangopadhyay J, Gygi SP, Reed R
Nucleic acids research 2018 Dec 14;46(22):11939-11951
Nucleic acids research 2018 Dec 14;46(22):11939-11951
Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
Davidson YS, Robinson AC, Hu Q, Mishra M, Baborie A, Jaros E, Perry RH, Cairns NJ, Richardson A, Gerhard A, Neary D, Snowden JS, Bigio EH, Mann DM
Neuropathology and applied neurobiology 2013 Feb;39(2):157-65
Neuropathology and applied neurobiology 2013 Feb;39(2):157-65
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, Ansorge O, Roeber S, Kretzschmar HA, Munoz DG, Kusaka H, Yokota O, Ang LC, Bilbao J, Rademakers R, Haass C, Mackenzie IR
Brain : a journal of neurology 2011 Sep;134(Pt 9):2595-609
Brain : a journal of neurology 2011 Sep;134(Pt 9):2595-609
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunoprecipitation: TAF15 Antibody [NB100-567] - Detection of human TAFII68 on HeLa whole cell lysate using NB100-567. TAFII68 was IPed with rabbit anti-TAFII68 antibodies NB100-566, NB100-567, NB100-568, and another using each at 0.3 ug/mg lysate.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: TAF15 Antibody [NB100-567] - FFPE section of human stomach adenocarcinoma. Affinity purified rabbit anti-TAFII68 used at a dilution of 1:250.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: TAF15 Antibody [NB100-567] - Sample: FFPE section of human testicular seminoma. Antibody: Affinity purified rabbit anti- TAFII68 used at a dilution of 1:5,000 (0.2ug/ml). Detection: DAB